Knowledge/Botox and Xeomin Botulinum Toxin: Composition, Results and How to Choose
Injectables

Botox and Xeomin Botulinum Toxin: Composition, Results and How to Choose

Both are highly purified botulinum toxin type A, but molecular structure and diffusion differ, so each has suitable uses.

Botox and Xeomin Botulinum Toxin: Composition, Results and How to Choose

Botox and Xeomin share the same core principle: highly purified botulinum toxin type A is used to precisely block acetylcholine release between nerve endings and muscle, temporarily relaxing overactive muscle and achieving wrinkle reduction, facial slimming and other effects.

Differences in composition and mechanism

ComparisonBotoxXeomin
OriginAllergan, USAMerz, Germany
Molecular structureCore neurotoxin plus complexing proteins (about 900 kDa)Pure botulinum toxin with zero complexing protein (about 150 kDa)
DiffusionWider spreadMore concentrated spread, favourable for precise fine-tuning

Suitable areas

  • Botox: well-developed masseter (softening the jawline), axillary hyperhidrosis and other larger-area targets
  • Xeomin: fine dynamic lines — glabellar lines, forehead lines, crow’s feet; more concentrated diffusion helps reduce the risk of eyelid ptosis

Results and safety

Both products are recognised by the FDA and the Hong Kong Department of Health. Common reactions are brief mild redness, swelling or bruising, which settle within a few days. Botox contains complexing proteins, so long-term, frequent, high-dose injection carries a higher chance of forming neutralizing antibodies; Xeomin has the complexing proteins removed, lowering the risk of an immune response. A “frozen face” usually comes from excessive dose or inaccurate injection depth, not from the brand itself, and must be performed by a registered doctor.

How to choose

  • For larger areas or a first injection, Botox may be chosen, given its extensive clinical database
  • For those who have had multiple injections and feel the effect has weakened, Xeomin is an alternative
  • Within the same treatment cycle, it is advisable to stay with a single brand
  • More is not better; overdosing increases antibody risk and may affect chewing function
Book ConsultationBack to knowledge